Names | |
---|---|
Preferred IUPAC name
Methyl 4-ethyl-6,7-dimethoxy-9H-pyrido[3,4-b]indole-3-carboxylate | |
Other names
DMCM | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider |
|
ECHA InfoCard | 100.220.168 |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C17H18N2O4 | |
Molar mass | 314.336 g/mol |
Boiling point | 87 °C (189 °F; 360 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
DMCM (methyl 6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) is a drug from the β-carboline family that induces anxiety and convulsions by acting as a negative allosteric modulatorofGABAA receptors — functionally opposite to benzodiazepines and related drugs which are positive allosteric modulators — and is used in scientific research for these properties to test new anxiolytic and anticonvulsant medications, respectively.[1][2][3][4] It has also been shown to produce analgesic effects in animals, which is thought to be the drug's induced panic reducing the perception of pain.[5]
| |
---|---|
GABA receptor antagonists |
|
GABA synthesis inhibitors |
|
Glycine receptor antagonists |
|
Glutamate receptor agonists |
|
Convulsant barbiturates |
|
Other |
|
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |